NAT and blood safety: what is the paradigm?

被引：51

作者：

Busch, MP

Dodd, RY

机构：

[1] Blood Ctr Pacific, San Francisco, CA 94118 USA

[2] Amer Red Cross, Jerome H Holland Lab, Rockville, MD 20855 USA

来源：

TRANSFUSION | 2000年 / 40卷 / 10期

关键词：

D O I：

10.1046/j.1537-2995.2000.40101157.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1157 / 1160

页数：4

相关论文

共 27 条

[21] A model of the health and economic impact of posttransfusion hepatitis C: application to cost-effectiveness analysis of further expansion of HCV screening protocols
Pereira, A
Sanz, C
[J]. TRANSFUSION, 2000, 40 (10) : 1182 - 1191
[22] The risk of transfusion-transmitted viral infections
Schreiber, GB
Busch, MP
Kleinman, SH
Korelitz, JJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) : 1685 - 1690
[23] Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
Schüttler, CG
Caspari, G
Jursch, CA
Willems, WR
Gerlich, WH
Schaefer, S
[J]. LANCET, 2000, 355 (9197) : 41 - 42
[24] Residues of NAT: questions and commentary
Sherman, LA
[J]. TRANSFUSION, 2000, 40 (10) : 1268 - 1272
[25] NAT of the United States and Canadian blood supply
Stramer, SL
Caglioti, S
Strong, DM
[J]. TRANSFUSION, 2000, 40 (10) : 1165 - 1168
[26] Tabor Edward, 2000, Transfusion (Bethesda), V40, P1273, DOI 10.1046/j.1537-2995.2000.40101273.x
[27] *WHO INT FED RED C, 2000, SAF BLOOD STARTS ME